| Quarter | Score |
|---|---|
| 2022-Q1 | 62.7 |
| 2022-Q3 | 74.3 |
| 2022-Q4 | 62.0 |
| 2023-Q1 | 49.3 |
| 2023-Q2 | 71.8 |
| 2023-Q3 | 50.5 |
| 2023-Q4 | 78.5 |
| 2024-Q1 | 53.2 |
| 2024-Q2 | 40.2 |
| 2024-Q3 | 83.8 |
| 2024-Q4 | 82.8 |
| 2025-Q1 | 81.8 |
| 2025-Q2 | 87.3 |
| 2025-Q3 | 87.1 |
| 2025-Q4 | 87.2 |
| 2026-Q1 | 87.0 |
| 2026-Q2 | 86.5 |
Solid consensus with smart money net adding at reasonable prices
Trading 55.8% below funds' estimated purchase price
2 of 18 tracked funds hold NVDA. Avg conviction: 2.1%. Net trimming. First tracked at $512.50 (current -55.8% vs tracked).
Appaloosa Management has 3.9% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Appaloosa Management | 3.9% | Add |
| Citadel Advisors | 0.3% | Reduce |